What is Immix Biopharma?I haven't looked into this company, but the chart looks interesting to me - and its ticker news shows it recently had some promising trial results.
−0.90USD
−15.43 MUSD
13.85 M
About Immix Biopharma, Inc.
Sector
CEO
Ilya Rachman
Headquarters
Los Angeles
Website
Employees (FY)
17
Founded
2012
FIGI
BBG00HLCWH09
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IMMX is 2.13 USD — it has decreased by 7.39% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Immix Biopharma, Inc. stocks are traded under the ticker IMMX.
Immix Biopharma, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
IMMX stock is 10.00% volatile and has beta coefficient of 1.58. Check out the list of the most volatile stocks — is Immix Biopharma, Inc. there?
Yes, you can track Immix Biopharma, Inc. financials in yearly and quarterly reports right on TradingView.
IMMX stock has fallen by 19.92% compared to the previous week, the month change is a 35.06% fall, over the last year Immix Biopharma, Inc. has showed a 18.33% increase.
IMMX net income for the last quarter is −5.09 M USD, while the quarter before that showed −4.28 M USD of net income which accounts for −18.90% change. Track more Immix Biopharma, Inc. financial stats to get the full picture.
Today Immix Biopharma, Inc. has the market capitalization of 60.71 M, it has decreased by 17.12% over the last week.
No, IMMX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IMMX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Immix Biopharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 17.00 employees. See our rating of the largest employees — is Immix Biopharma, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Immix Biopharma, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Immix Biopharma, Inc. stock shows the strong sell signal. See more of Immix Biopharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.